Stock Comparison
AZN vs LLY
AstraZeneca PLC and Eli Lilly and Company side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$292.20B
$1.08T
P/E (TTM)
28.4
42.9
Forward P/E
17.9
31.1
Price/Sales
4.8
14.9
Price/Book
6.2
32.2
EV/EBITDA
15.8
28.8
Dividend Yield
1.72%
0.55%
Profitability
Net Margin
17.20%
35.00%
Operating Margin
27.90%
49.40%
Return on Equity
23.50%
107.50%
Return on Assets
8.49%
20.70%
Growth (YoY)
Revenue Growth
12.50%
55.50%
Earnings Growth
5.30%
169.90%
Price & Risk
Beta
0.2
0.5
52-Week High
$210.50
$1,215.76
52-Week Low
$134.85
$619.40
Analyst Target
$224.49
$1,222.62
Compare AZN and LLY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.